垂体腺瘤中磷酸化p38、基质金属蛋白酶9与MHC I类链相关分子A表达的关系揭示垂体腺瘤免疫逃逸新机制
该研究通过免疫组化、实时定量RT-PCR和Western blot检测垂体腺瘤组织中磷酸化p38、MMP-9和MICA的mRNA及蛋白表达,并用ELISA检测患者血清MMP-9和sMICA水平。结果发现垂体腺瘤中p38、MICA和MMP-9 mRNA水平高于正常组织,磷酸化p38、MMP-9和MICA蛋白过表达,且MMP-9和MICA表达与磷酸化p38表达呈正相关;患者血清sMICA和MMP-9蛋白水平显著高于正常对照。结论提示p38/MAPK通路激活可能增加MICA表达并诱导MMP-9表达,MMP-9参与sMICA从MICA脱落以促进肿瘤免疫逃逸。
要点
- 垂体腺瘤组织中p38、MICA和MMP-9 mRNA水平高于正常组织。
- 垂体腺瘤中磷酸化p38、MMP-9和MICA蛋白过表达,MMP-9和MICA表达与磷酸化p38表达呈正相关。
- 垂体腺瘤患者血清sMICA和MMP-9蛋白水平显著高于正常对照。
核心结论
- 这些发现提示p38/丝裂原活化蛋白激酶通路激活可能增加MICA表达并诱导MMP-9表达。
- MMP-9参与sMICA从MICA脱落以促进肿瘤免疫逃逸。
- p38/丝裂原活化蛋白激酶可能代表抑制垂体腺瘤免疫逃逸的新靶点。
研究设计与样本
- 研究采用免疫组织化学、实时定量逆转录聚合酶链反应和Western blot检测垂体腺瘤组织中磷酸化p38、MMP-9和MICA在mRNA和蛋白水平的表达。
- 采用酶联免疫吸附试验检测垂体腺瘤患者外周血血清中MMP-9和sMICA的表达水平。
主要发现
- 垂体腺瘤中p38、MICA和MMP-9 mRNA水平高于正常组织。
- 垂体腺瘤中磷酸化p38、MMP-9和MICA蛋白过表达,MMP-9和MICA表达与磷酸化p38表达呈正相关。
- 垂体腺瘤患者血清sMICA和MMP-9蛋白水平显著高于正常对照。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The major histocompatibility complex class I chain-related molecule A (MICA) is one of the natural killer group 2D ligands. Soluble major histocompatibility complex class I chain-related molecule A (sMICA) mediates tumor immune escape, but the mechanism is not fully understood. In this study, we examined the expression of phospho-p38, matrix metalloproteinase 9 (MMP-9), and MICA and their relationships among each other in pituitary adenoma tissues to provide a histologic basis for the mechanism of pituitary adenoma immune escape. METHODS: We applied immunohistochemistry, real-time quantitative reverse-transcriptase polymerase chain reaction, and Western blot to detect phospho-p38, MMP-9, and MICA expression at the mRNA and protein levels in pituitary adenoma tissues. Enzyme-linked immunosorbent assay was used to examine the expression levels of MMP-9 and sMICA in peripheral blood serum from patients with pituitary adenoma. RESULTS: We found that p38, MICA, and MMP-9 mRNA levels were greater in pituitary adenomas than in normal tissues. The phospho-p38, MMP-9, and MICA proteins were overexpressed in pituitary adenomas, and the expression of MMP-9 and MICA were positively correlated with the expression of phospho-p38. In addition, the serum levels of sMICA and MMP-9 proteins in pituitary adenoma patients were significantly greater than those in normal controls. CONCLUSIONS: These findings suggest that activation of the p38/mitogen-activated protein kinase pathway may increase MICA expression and induce MMP-9 expression. MMP-9 is involved in the shedding of sMICA from MICA to promote tumor immune escape. Furthermore, p38/mitogen-activated protein kinase could potentially represent a novel target for inhibiting pituitary adenoma immune escape.
引用
- Han X, Geng X, Li Z, et al. The Relationship Between Phospho-p38, Matrix Metalloproteinase 9, and Major Histocompatibility Complex Class I Chain-Related Molecule A Expression in Pituitary Adenomas Demonstrates a New Mechanism of Pituitary Adenoma Immune Escape. World Neurosurg. 2018. PMID: 30458325. doi:10.1016/j.wneu.2018.11.077
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。